Abstract
In a phase II/III clinical trial intraperitoneal (i.p.) administration of a group C adenovirus vector (Ad5) caused bowel adhesion formation, perforation and obstruction. However, we had found that i.p. group B, in contrast to group C adenoviruses, did not cause adhesions in nude BALB/c ovarian cancer models, prompting further investigation. Ex vivo, group B Ad11 caused lower inflammatory responses than Ad5 on BALB/c peritoneal macrophages. In vivo, i.p. Ad11 triggered short-term cytokine and cellular responses equal to Ad5 in both human CD46-positive and -negative mice. In contrast, in a long-term study of repeated i.p. administration, Ad11 caused no/mild, whereas Ad5 induced moderate/severe adhesions and substantial liver toxicity accompanied by elevated levels of IFN gamma and VEGF and loss of i.p. macrophages, regardless of CD46 expression. It appears that, although i.p. Ad11 evokes immediate inflammation similar to Ad5, repeated administration of Ad11 is better tolerated and long-term fibrotic tissue remodelling is reduced.
Original language | English |
---|---|
Article number | N/A |
Pages (from-to) | 74-83 |
Number of pages | 10 |
Journal | Virology |
Volume | 447 |
Issue number | 1-2 |
DOIs | |
Publication status | Published - Dec 2013 |
Keywords
- Adenovirus
- Ad5
- Ad11
- Intraperitoneal inflammation
- Ovarian cancer
- Gene therapy
- Virotherapy
- CD46-transgenic mice
- COMPLEMENT-REGULATORY PROTEINS
- PERITONEAL ADHESION FORMATION
- GROWTH-FACTOR RECEPTOR
- KINASE GENE-THERAPY
- CELLULAR RECEPTOR
- SPECIES-B
- FOLLOW-UP
- IN-VIVO
- PHASE-I
- MACROPHAGE